Page last updated: 2024-09-04

cox 189 and plx4032

cox 189 has been researched along with plx4032 in 1 studies

Compound Research Comparison

Studies
(cox 189)
Trials
(cox 189)
Recent Studies (post-2010)
(cox 189)
Studies
(plx4032)
Trials
(plx4032)
Recent Studies (post-2010) (plx4032)
16349471,6571031,587

Protein Interaction Comparison

ProteinTaxonomycox 189 (IC50)plx4032 (IC50)
Chain A, AKAP9-BRAF fusion proteinHomo sapiens (human)0.031
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.182
Serine/threonine-protein kinase A-RafHomo sapiens (human)0.521
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.0897
Serine/threonine-protein kinase B-raf Mus musculus (house mouse)0.03
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.36
Dual specificity mitogen-activated protein kinase kinase 2Homo sapiens (human)1.5
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)1.5
Mitogen-activated protein kinase kinase kinase 20Homo sapiens (human)0.0272

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blank, C; Brummer, C; Bruss, C; Faerber, S; Haferkamp, S; Herr, W; Kreutz, M; Lacroix, R; Renner, K1

Other Studies

1 other study(ies) available for cox 189 and plx4032

ArticleYear
Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma.
    Cancer letters, 2019, 02-01, Volume: 442

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diclofenac; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Genetic Predisposition to Disease; Humans; Melanoma; Mitogen-Activated Protein Kinases; Mutation; Phenotype; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Time Factors; Vemurafenib

2019